Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 333-337

  Alos J I ^a   Aracil, B ^a   Oteo, J ^a   Gomez Garces J L ^a   Abaldi Marino M ^b   Lueiro, F ^c   Bermudez P ^c   Perez Trallero E ^d   Prats, G ^e   Mirelis, B ^e   Cervera, M ^t   Roig, G ^t   Gomez Lus R ^f   Garcia Garcia C ^f   Garcia Moya J ^g   Villuendas, M C ^g   Marco, A ^g   Perez Pascual P ^h   Carrero, P ⁱ   Bixquert, J ^j   Perez Pomata T ^j   Orden, B ^k   de la Torre, F ^l   Wilhelmi, I ^m   Garcia Hierro P ⁿ   Dominguez J R ⁿ   Maiquez, J ^o   Segovia, M ^p   Menasalbes, A ^p   de la Rosa, M ^q   Martinez Brocal A ^q   Martin E ^r   Marin P ^s   more..

^a HOSPITAL DE MÓSTOLES   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL MONTECELO   (Spain)

^d Hospital Nuestra Senora de Aranzazu   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^h HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

ⁱ HOSPITAL GENERAL DE SEGOVIA   (Spain)

^j HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^k Ambulatorio de Argüelles   (Spain)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m HOSPITAL SEVERO OCHOA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^o INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^p HOSPITAL MORALES MESEGUER   (Spain)

^q HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^r HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^s HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^t NONE

more..

Author keywords

Antimicrobial resistance; Erythromycin resistance; Group A streptococci; M phenotype

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIOKAMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE IDENTIFICATION; GEOGRAPHIC DISTRIBUTION; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPIC VARIATION; PREVALENCE; SPAIN; STATISTICAL ANALYSIS; STREPTOCOCCUS PYOGENES; THROAT CULTURE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MIOCAMYCIN; PHENOTYPE; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0037323799     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg100     Document Type: Article

References (29)

1. Bisno, A. L. (2001). Acute pharyngitis. New England Journal of Medicine 344, 205-11.
2. Macris, M. H., Hartman, N., Murray, B., Klein, R. F., Roberts, R. B., Kaplan, E. L. et al. (1998). Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatric Infectious Diseases Journal 17, 377-81.
3. Palavecino, E. L., Riedel, I., Berrios, X., Bajaksouzian, S., Johnson, D., Kaplan, E. et al. (2001). Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrobial Agents and Chemotherapy 45, 339-41.
4. Martin, J. M., Green, M., Barbadora, K. A. & Wald, E. R. (2002). Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. New England Journal of Medicine 346, 1200-6.
5. Stamos, G., Bedevis, K., Paraskaki, I., Chronopoulou, A., Tsirepa, M. & Foustoukou, M. (2001). Emergence of group A beta-hemolytic streptococci resistant to erythromycin in Athens, Greece. European Journal of Clinical Microbiology and Infectious Diseases 20, 70-1.
6. Cizman, M., Pokorn, M., Seme, K., Orazem, A. & Paragi, M. (2001). The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. Journal of Antimicrobial Chemotherapy 47, 475-7.
7. Cha, S., Lee, H., Lee, K., Hwang, K., Bae, S. & Lee, Y. (2001). The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea. Journal of Infectious Chemotherapy 7, 81-6.
8. Bassetti, M., Manno, G., Collida, A., Ferrando, A., Gatti, G. & Ugolotti, E. (2000). Erythromycin resistance in Streptococcus pyogenes in Italy. Emerging Infectious Diseases 6, 180-3.
9. Syrogiannopoulos, G. A., Grivea, I. N., Fitoussi, F., Doit, C., Katopodis, G. D., Bingen, E. et al. (2001). High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatric Infectious Disease Journal 20, 863-8.
10. Alós, J. I., Aracil, B., Oteo, J., Torres, C., Gómez-Garcés, J. L. & the Spanish Group for the Study of Infection in the Primary Health Care Setting. (2000). High prevalence of erythromycin-resistant, clindamycin, and miocamycin-susceptible (M-phenotype) Streptococcus pyogenes: results of a multicenter study performed in 1998 in Spain. Journal of Antimicrobial Chemotherapy 45, 605-9.
11. Ruoff, K. L., Whiley, R. A. & Beighton, D. (1999). Streptococcus. In Manual of Clinical Microbiology, 7th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 283-96. American Society for Microbiology, Washington, DC, USA.
12. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
13. National Committee for Clinical Laboratory Standards. (2001). Performance Standards for Antimicrobial Susceptibility Testing-Eleventh Informational Supplement: M100-S11. NCCLS, Wayne, PA, USA.
14. Societé Française de Microbiologie. (1996). Statement 1996 CA-SFM zone sizes and MIC breakpoints for non-fastidious organisms. Clinical Microbiology and Infection 2, Suppl. 1, S46-9.
15. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
16. Arthur, M., Molinas, C. & Mabilat, C. (1993). PCR detection of erm erythromycin resistance genes by using degenerate oligonucleotide primers. In Diagnostic Molecular Microbiology (Persing, D. H., Smith, T. F., Tenover, F. C. & White, T. J., Eds), pp. 534-8. American Society for Microbiology, Washington, DC, USA.
17. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
18. Kataja, J., Seppälä, H., Skurnik, M., Sarkkinen, H. & Huovinen, P. (1998). Different erythromycin resistance mechanism in group C and group G streptococci. Antimicrobial Agents and Chemotherapy 42, 1493-4.
19. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolicles but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
20. Schegel, L., Merad, B., Rostane H., Broc, V. & Bouvet, A. (2001). In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999. Clinical Microbiology and Infection 7, 362-6.
21. Kaplan, E. L., Johnson, D. R., del Rosario, M. C. & Horn, D. L. (1999). Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatric Infectious Disease Journal 18, 1069-72.
22. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C., Bouza, E., Aguilar, L., García-de-Lomas, J. et al. (2001). Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
23. Baquero, F., García-Rodríguez, J. A., García de Lomas, J., Aguilar L. & the Spanish Surveillance Group for Respiratory Pathogens. (1999). Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrobial Agents and Chemotherapy 43, 178-80.
24. Granizo, J. J., Aguilar, L., Casal, J., Dal-Ré, R. & Baquero, F. (2000). Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). Journal of Antimicrobial Chemotherapy 46, 959-64.
25. Seppälä, H., Klaukka, T., Lehtonen, R., Nenonen, E., the Finnish Study Group for Antimicrobial Resistance & Huovinen, P. (1995). Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases 21, 1378-85.
26. García-Rey, C., Aguilar, L., Baquero, F., Casal, J. & Martín, J. (2002). Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. Journal of Clinical Microbiology 40, 2959-63.
27. Aracil, B., Minambres, M., Oteo, J., Torres, C., Gómez-Garcés, J. L. & Alós, J. I. (2001). High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. Journal of Antimicrobial Chemotherapy 48, 592-4.
28. Pérez-Trallero, E., Vicente, D., Montes, M., Marimon, J. M. & Piñeiro, L. (2001). High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. Journal of Antimicrobial Chemotherapy 48, 225-9.
29. Facinelli, B., Spinaci, C., Magi, G., Giovanetti, E. & Varaldo, P. E. (2001). Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358, 30-3.